Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

CYTK

Cytokinetics (CYTK)

Cytokinetics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CYTK
FechaHoraFuenteTítuloSímboloCompañía
03/01/202515:00GlobeNewswire Inc.Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:CYTKCytokinetics Inc
23/12/202406:30GlobeNewswire Inc.Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic CardiomyopathyNASDAQ:CYTKCytokinetics Inc
19/12/202423:00GlobeNewswire Inc.Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater ChinaNASDAQ:CYTKCytokinetics Inc
16/12/202418:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
16/12/202415:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTKCytokinetics Inc
16/12/202415:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
03/12/202415:00GlobeNewswire Inc.Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CYTKCytokinetics Inc
03/12/202406:30GlobeNewswire Inc.Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection FractionNASDAQ:CYTKCytokinetics Inc
02/12/202415:00GlobeNewswire Inc.Cytokinetics to Participate in December Investor ConferencesNASDAQ:CYTKCytokinetics Inc
02/12/202406:30GlobeNewswire Inc.Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic CardiomyopathyNASDAQ:CYTKCytokinetics Inc
19/11/202401:30GlobeNewswire Inc.Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in JapanNASDAQ:CYTKCytokinetics Inc
16/11/202408:00GlobeNewswire Inc.Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024NASDAQ:CYTKCytokinetics Inc
16/11/202408:00GlobeNewswire Inc.Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024NASDAQ:CYTKCytokinetics Inc
14/11/202412:28Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CYTKCytokinetics Inc
12/11/202415:00GlobeNewswire Inc.Cytokinetics to Participate in the 2024 Jefferies London Healthcare ConferenceNASDAQ:CYTKCytokinetics Inc
12/11/202410:44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CYTKCytokinetics Inc
11/11/202406:30GlobeNewswire Inc.Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089NASDAQ:CYTKCytokinetics Inc
07/11/202415:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYTKCytokinetics Inc
06/11/202415:00GlobeNewswire Inc.Cytokinetics Reports Third Quarter 2024 Financial ResultsNASDAQ:CYTKCytokinetics Inc
05/11/202415:00GlobeNewswire Inc.Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024NASDAQ:CYTKCytokinetics Inc
23/10/202415:00GlobeNewswire Inc.Cytokinetics to Announce Third Quarter Results on November 6, 2024NASDAQ:CYTKCytokinetics Inc
16/10/202406:30GlobeNewswire Inc.Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst DayNASDAQ:CYTKCytokinetics Inc
02/10/202415:00GlobeNewswire Inc.Cytokinetics to Host Investor & Analyst Day on October 16, 2024NASDAQ:CYTKCytokinetics Inc
30/09/202408:20GlobeNewswire Inc.Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific MeetingNASDAQ:CYTKCytokinetics Inc
27/09/202410:00GlobeNewswire Inc.Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific SessionsNASDAQ:CYTKCytokinetics Inc
24/09/202406:30GlobeNewswire Inc.Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant ProgramNASDAQ:CYTKCytokinetics Inc
19/09/202415:00GlobeNewswire Inc.Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific MeetingNASDAQ:CYTKCytokinetics Inc
09/09/202406:30GlobeNewswire Inc.Cytokinetics Announces Data From Phase 1 Study of CK-4021586NASDAQ:CYTKCytokinetics Inc
05/09/202415:00GlobeNewswire Inc.Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual MeetingNASDAQ:CYTKCytokinetics Inc
01/09/202403:27GlobeNewswire Inc.Cytokinetics Presents New Data Related to the Safety and Long-Term Use of Aficamten at the European Society of Cardiology Congress 2024NASDAQ:CYTKCytokinetics Inc
 Showing the most relevant articles for your search:NASDAQ:CYTK

Su Consulta Reciente

Delayed Upgrade Clock